Literature DB >> 27484150

Spatiotemporal dynamics of autophagy receptors in selective mitophagy.

Andrew S Moore1, Erika L F Holzbaur1.   

Abstract

Damaged mitochondria are turned over through a process of selective autophagy termed mitophagy. In mitophagy, unhealthy mitochondria are recognized and ubiquitinated by Parkinson disease-linked proteins PINK1 and PARK2. The subsequent recruitment of ubiquitin-binding autophagy receptors leads in turn to the sequestration of the damaged organelles into LC3-positive phagophores, precursors to autophagosomes. The precise identity of these receptors and how they are regulated has been the focus of considerable attention. Our recent work uses live-cell imaging to explore the dynamics and regulation of autophagy receptor recruitment. Utilizing multiple paradigms to induce mitochondrial damage, we identified the rapid, 2-step recruitment of autophagy receptors OPTN, CALCOCO2/NDP52, and TAX1BP1. All 3 receptors are recruited to damaged mitochondria with similar kinetics; however, only OPTN is necessary for efficient formation of a phagophore sequestering damaged mitochondria from the cytosol. OPTN is co-recruited to damaged mitochondria along with its upstream kinase TBK1. Depletion of OPTN or TBK1, or expression of amyotrophic lateral sclerosis (ALS)-linked mutations in either protein, interfere with efficient autophagic engulfment of depolarized mitochondria. These observations suggest that insufficient autophagy of damaged mitochondria may contribute to neurodegenerative disease.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27484150      PMCID: PMC5079667          DOI: 10.1080/15548627.2016.1212788

Source DB:  PubMed          Journal:  Autophagy        ISSN: 1554-8627            Impact factor:   16.016


  15 in total

1.  The TBK1-OPTN Axis Mediates Crosstalk Between Mitophagy and the Innate Immune Response: A Potential Therapeutic Target for Neurodegenerative Diseases.

Authors:  Lu He; Linxi Chen; Lanfang Li
Journal:  Neurosci Bull       Date:  2017-03-07       Impact factor: 5.203

Review 2.  Mediators of mitophagy that regulate mitochondrial quality control play crucial role in diverse pathophysiology.

Authors:  Rudranil De; Somnath Mazumder; Uday Bandyopadhyay
Journal:  Cell Biol Toxicol       Date:  2020-10-17       Impact factor: 6.691

Review 3.  On the offense and defense: mitochondrial recovery programs amidst targeted pathogenic assault.

Authors:  Siraje A Mahmud; Mohammed A Qureshi; Mark W Pellegrino
Journal:  FEBS J       Date:  2021-07-16       Impact factor: 5.622

Review 4.  Mitophagy in Parkinson's Disease: Pathogenic and Therapeutic Implications.

Authors:  Fei Gao; Jia Yang; Dongdong Wang; Chao Li; Yi Fu; Huaishan Wang; Wei He; Jianmin Zhang
Journal:  Front Neurol       Date:  2017-10-04       Impact factor: 4.003

Review 5.  Dysfunction of Optineurin in Amyotrophic Lateral Sclerosis and Glaucoma.

Authors:  Reka P Toth; Julie D Atkin
Journal:  Front Immunol       Date:  2018-05-23       Impact factor: 7.561

Review 6.  Mitochondrial quality control and neurodegenerative diseases.

Authors:  Fei Gao; Jianmin Zhang
Journal:  Neuronal Signal       Date:  2018-12-03

Review 7.  Role of Optineurin in the Mitochondrial Dysfunction: Potential Implications in Neurodegenerative Diseases and Cancer.

Authors:  Robert Weil; Emmanuel Laplantine; Shannel Curic; Pierre Génin
Journal:  Front Immunol       Date:  2018-06-19       Impact factor: 7.561

Review 8.  Altered Functions and Interactions of Glaucoma-Associated Mutants of Optineurin.

Authors:  Ghanshyam Swarup; Zuberwasim Sayyad
Journal:  Front Immunol       Date:  2018-06-06       Impact factor: 7.561

Review 9.  A Molecular Approach to Mitophagy and Mitochondrial Dynamics.

Authors:  Seung-Min Yoo; Yong-Keun Jung
Journal:  Mol Cells       Date:  2018-01-23       Impact factor: 5.034

Review 10.  Mechanisms and roles of mitophagy in neurodegenerative diseases.

Authors:  Yan Wang; Na Liu; Bingwei Lu
Journal:  CNS Neurosci Ther       Date:  2019-05-02       Impact factor: 5.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.